IONS: Underwent a brutal sell off from its highs in Mar 2015 at $77.80 to a low of $19.59 in May 2016. A stock which underwent sell off of 75% warrants a look by bargain hunters. IONS partnership with BIIB just obtained EU approval for a 125K/treatment for spinal disease. This will inevidentably be just the antidote that IONS needs to return to its new highs and more. A break below Minute Wave ii will require adjustment of the wave counts.
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.